Latest Breaking News On - William richard white - Page 1 : vimarsana.com

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells 2,831 Shares of Stock

Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) CFO William Richard White sold 2,831 shares of the company’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $22.64, for a total value of $64,093.84. Following the completion of the sale, the chief financial officer now directly owns […]

Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $85.00 price objective on the stock. Several other equities research analysts also recently commented on the company. Morgan Stanley reduced their target price on Disc […]

Disc Medicine's (IRON) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $85.00 target price on the stock. IRON has been the subject of a number of other reports. Wedbush reaffirmed an outperform rating and set a $43.00 price […]

Disc Medicine (NASDAQ:IRON) Stock Rating Reaffirmed by Cantor Fitzgerald

Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “overweight” rating restated by stock analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They currently have a $85.00 price target on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 148.97% from the company’s current price. Several […]

Disc Medicine's (IRON) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $85.00 price target on the stock. Several other research analysts have also weighed in on IRON. Stifel Nicolaus upped their price target on Disc Medicine from […]

Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of "Moderate Buy" from Analysts

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price […]

HC Wainwright Reiterates "Buy" Rating for Disc Medicine (NASDAQ:IRON)

Disc Medicine (NASDAQ:IRON) PT Raised to $43.00 at Raymond James

Raymond James Increases Disc Medicine (NASDAQ:IRON) Price Target to $43.00

Flick Fact: That garage door opener of yours? Where was it born?